Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use GUANFACINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for GUANFACINE EXTENDED-RELEASE TABLETS. GUANFACINE extended-release tablets, for oral use Initial U.S. Approval: 1986
Medication labelWhy this: Advisory · dailymed-prescription
Guanfacine extended-release tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [ see CLINICAL STUDIES ( 14 ) ].
- generic_name
- guanfacine
- product_names
- Guanfacine
- ndc
- 71205-944, 71205-945, 71205-946, 71205-947, 24979-533, 71205-944-30, 71205-944-60, 71205-944-90, 71205-944-00, 71205-944-55, 24979-534, 71205-945-30, 71205-945-60, 71205-945-90, 71205-945-00, 71205-945-55, 24979-536, 71205-946-30, 71205-946-60, 71205-946-90, 71205-946-00, 71205-946-55, 24979-538, 71205-947-30, 71205-947-60, 71205-947-90, 71205-947-00, 71205-947-55
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en